Bellato, Rhael Vincent -.

HRN: 23-05-26  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
AMPICILLIN 250MG (VIAL)
06/01/2023
06/14/2023
IV
250mg
Q12
PSNB
Waiting Final Action 
06/01/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/01/2023
06/14/2023
IV
50mg
OD
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: